最近和预期的新药批准 (2025年第一季度至2025年第四季度)
Matthew H Rim1, Brittany L Karas1, Farah Barada1
1Northwestern Medicine, Chicago, IL, USA.
概括
医疗系统药剂师可以为2025年新药批准做好准备,包括基因疗法和癌症治疗. 这个管道更新有助于配方管理和新疗法的资源配置.
科学领域:
- 制药科学 制药科学
- 药物经济学 药物经济学
- 临床药房 临床药房
背景情况:
- 医疗系统药剂师对于管理药物配方和优化患者护理至关重要.
- 监测制药管道对于战略资源配置和临床计划开发至关重要.
- 预测新药的批准,可以为新的治疗干预措施进行主动规划.
研究的目的:
- 为医疗系统药剂师提供有关新药和预期新药批准的最新信息.
- 支持药剂师管理配方,分配资源和优化临床计划.
- 突出预计在医疗保健环境中具有重大临床和财务影响的药物.
主要方法:
- 预计在2025年对选定的药物批准进行审查.
- 对等待美国食品和药物管理局 (FDA) 批准的新药的分析.
- 专注于在医院和诊所具有潜在显著临床和财务影响的药物.
主要成果:
- 2025年的药物管道包括用于罕见疾病的基因和细胞疗法.
- 预期批准的特点是治疗神经系统疾病的药物和新的癌症治疗方法.
- 该分析涵盖了大约60种新药,预计将获得FDA批准.
结论:
- 新型疗法正在不断增强制药管道.
- 积极监测药物批准对卫生系统药房实践至关重要.
- 即将到来的新型药物的新浪潮承诺在各种疾病状态中取得重大进展.
更多相关视频
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
285
06:26Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
885
相关概念视频
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Drug Discovery: Overview
7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Nomenclature
1.6K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.6K
Prescription, Nonprescription and Orphan Drugs
677
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
677
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
